首页> 外文OA文献 >Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfa

【2h】

Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfa

机译：法布里氏病患者进行酶替代治疗以及从阿加糖酶β转换为阿加糖酶α的临床观察

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lin Hsiang-Yu; Huang Yu-Hsiu; Liao Hsuan-Chieh; Liu Hao-Chuan; Hsu Ting-Rong; Shen Chia-I; Li Shao-Tzu; Li Cheng-Fang; Lee Li-Hong; Lee Pi-Chang; Huang Chun-Kai; Chiang Chuan-Chi; Lin Shuan-Pei; Niu Dau-Ming;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfa [J] . Hsiang-Yu Lin, Yu-Hsiu Huang, Hsuan-Chieh Liao, Journal of the Chinese Medical Association: JCMA . 2014,第4期

机译：法布里病患者进行酶替代治疗以及从阿糖苷酶β转换为阿糖苷酶α的临床观察
2. Switch from agalsidase beta to agalsidase alfa in the enzyme replacement therapy of patients with fabry disease in Latin America [J] . Ripeau Diego, Amartino Hernán, Cedrolla Martín, Medicina (Buenos Aires) . 2017,第3期

机译：在拉丁美洲的Fabry病患者的酶替代治疗中，从阿糖苷酶β转换为阿糖苷酶α
3. Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal) [J] . TsuboiK., YamamotoH. Genetics in medicine . 2012,第9期

机译：从Agalsidase beta（Fabrazyme）切换至Algalsidase alfa（Replagal）后，Fabry病患者的临床观察
4. Endothelial Targeted Enzyme Replacement Therapy for Fabry Disease [C] . D. Serrano, J. Hsu, K.V.N. Kumar, Annual meeting exposition of the Controlled Release Society . 2009

机译：Fabry病的内皮靶向酶替代治疗
5. Concurrent validity and responsiveness of the Peabody Developmental Motor Scales-2 in infants and children with Pompe disease undergoing enzyme replacement therapy [D] . Phillips, Dawn. 2012

机译：皮博迪发育运动量表2在接受酶替代疗法的庞贝病婴儿和儿童中的并发有效性和反应性
6. Successful Management of Enzyme Replacement Therapy in Related Fabry Disease Patients with Severe Adverse Events by Switching from Agalsidase Beta (Fabrazyme®) to Agalsidase Alfa (Replagal®) [O] . Kazuya Tsuboi, Hiroshi Yamamoto, Fuji Somura, 2015

机译：从严重的不良事件相关的法布里病患者中成功进行酶替代疗法的管理方法是从Agalsidase Beta（Fabrazyme®）转换为Agalsidase Alfa（Replagal®）
7. Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfa [O] . Hsiang-Yu Lin, Yu-Hsiu Huang, Hsuan-Chieh Liao, 2014

机译：法布里病患者酶替代疗法及从阿加糖酶β转换为阿加糖酶α的临床观察
8. Pilot Scale Isolation of Ceramide Trihexosidase from Human Plasma and Clinical Evaluation of Enzyme Replacement Therapy in Fabry's Disease. [R] . sweeley,charles c. 1975

机译：人体血浆中神经酰胺三己糖苷酶的中试分离及法布里氏病酶替代疗法的临床评价。

Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfa

著录项

引文网络

相似文献

相关主题

期刊订阅